Frenalytics
PrivateLast Round
Grant
Jul 19, 2023
Total Funding Raised
$320,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Frenalytics operates in Enterprise Software and is based in Rockville Centre, New York. Its latest recorded funding round was a Grant round in July 2023.
Frenalytics is an educational software company that develops a cloud-based interactive platform designed to address learning issues due to cognitive deficits.
Sector
Enterprise Software
Verticals
Vertical SaaS, Compliance, Data Visualization, Workflow Automation, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium, Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Frenalytics Comparables
Compare Frenalytics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IEP Solutions, LLC | 83% | |
| Playground IEP | 82% | |
| AbleSpace | 82% |
For institutional investors. Book with your work email.
Frenalytics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 19, 2023 | ||||
| Pre Seed | Mar 24, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Frenalytics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Right Side Capital Management | Pre Seed |
| Schmidt Futures | Grant |
| Gates Foundation | Grant |
| Shor Capital | Pre Seed |
| Walton Family Foundation | Grant |
| Forum Ventures | Pre Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 47% MoM, reaching 3.1K.
- Mar 1, 2026
Monthly visitors grew 42% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asSep 17, 2026
On Sep 22nd '26 in New York, Frenalytics was selected as one of 27 teams advancing to the Discovery Phase of the ATS Hub Ideas Challenge, an initiative of Digital Promise.
- recognized_asSep 17, 2026
Digital Promise's ATS Hub Ideas Challenge selected Frenalytics as one of 27 teams advancing to the Discovery Phase, with its IEP Progress Pathway named among the top nine submissions in the 6-12 Track serving Grades 6 to 12, in New York on Sep 22nd '26.
For institutional investors. Book with your work email.
Frenalytics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Frenalytics's valuation, stock price, and market status.
Is Frenalytics a public or private company?
Frenalytics is a private company.
What is the current stock price of Frenalytics?
Frenalytics is a private company, so its shares have no public market price. Caplight tracks Frenalytics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Frenalytics worth (valuation)?
Valuation information for Frenalytics is not publicly available.
Can I buy Frenalytics stock?
Frenalytics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Frenalytics's last funding round?
Frenalytics's most recent funding round was Grant on July 19, 2023.
Who are the main investors in Frenalytics?
Key investors in Frenalytics include Forum Ventures.
Will Frenalytics IPO soon?
No public IPO plans have been announced for Frenalytics.
How can I track Frenalytics secondary market activity?
Caplight tracks bids, offers, and trades in Frenalytics's shares on secondary markets.